These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9867064

  • 1. Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study.
    Nankervis A, Nicholls K, Kilmartin G, Allen P, Ratnaike S, Martin FI.
    Metabolism; 1998 Dec; 47(12 Suppl 1):12-5. PubMed ID: 9867064
    [Abstract] [Full Text] [Related]

  • 2. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.
    Ahmad J, Shafique S, Abidi SM, Parwez I.
    Diabetes Res Clin Pract; 2003 May; 60(2):131-8. PubMed ID: 12706322
    [Abstract] [Full Text] [Related]

  • 3. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan 26; 302(6770):210-6. PubMed ID: 1998761
    [Abstract] [Full Text] [Related]

  • 4. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Hermans MP, Brichard SM, Colin I, Borgies P, Ketelslegers JM, Lambert AE.
    Am J Med; 1992 Apr 27; 92(4B):102S-107S. PubMed ID: 1580274
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
    Rudberg S, Osterby R, Bangstad HJ, Dahlquist G, Persson B.
    Diabetologia; 1999 May 27; 42(5):589-95. PubMed ID: 10333052
    [Abstract] [Full Text] [Related]

  • 11. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC, Cooper ME, Jerums G, Doyle AE.
    Diabetes; 1993 Apr 27; 42(4):604-9. PubMed ID: 8454112
    [Abstract] [Full Text] [Related]

  • 12. [Protective effect of angiotensin coverting enzyme inhibitor on renal function in normotensive non-insulin dependent diabetes mellitus patients with early diabetic nephropathy and microalbuminuria].
    Xia H, He R, Chen J.
    Zhonghua Nei Ke Za Zhi; 1996 Aug 27; 35(8):533-6. PubMed ID: 9594145
    [Abstract] [Full Text] [Related]

  • 13. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov 27; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 14. WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Lovell HG.
    Cochrane Database Syst Rev; 2007 Jul 18; (1):CD002183. PubMed ID: 17636698
    [Abstract] [Full Text] [Related]

  • 15. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.
    Am J Kidney Dis; 2001 May 18; 37(5):890-9. PubMed ID: 11325669
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Lovell HG.
    Cochrane Database Syst Rev; 2001 May 18; (1):CD002183. PubMed ID: 11279757
    [Abstract] [Full Text] [Related]

  • 17. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S, Ketelslegers JM, Lambert AE.
    Clin Exp Hypertens A; 1989 May 18; 11 Suppl 2():545-54. PubMed ID: 2691128
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.
    Kidney Int; 2000 Feb 18; 57(2):590-600. PubMed ID: 10652036
    [Abstract] [Full Text] [Related]

  • 19. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM, Santoni JP, Thomas JR, van de Voorde K, Ketelslegers JM, Lambert AE.
    Diabete Metab; 1990 Feb 18; 16(1):30-6. PubMed ID: 2185055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.